145 related articles for article (PubMed ID: 38270218)
21. Identification of reliable biomarkers of human papillomavirus 16 methylation in cervical lesions based on integration status using high-resolution melting analysis.
Liu L; Ying C; Zhao Z; Sui L; Zhang X; Qian C; Wang Q; Chen L; Guo Q; Wu J
Clin Epigenetics; 2018; 10():10. PubMed ID: 29410710
[TBL] [Abstract][Full Text] [Related]
22. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis.
Bowden SJ; Kalliala I; Veroniki AA; Arbyn M; Mitra A; Lathouras K; Mirabello L; Chadeau-Hyam M; Paraskevaidis E; Flanagan JM; Kyrgiou M
EBioMedicine; 2019 Dec; 50():246-259. PubMed ID: 31732479
[TBL] [Abstract][Full Text] [Related]
23. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
[TBL] [Abstract][Full Text] [Related]
25. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation.
Badal S; Badal V; Calleja-Macias IE; Kalantari M; Chuang LS; Li BF; Bernard HU
Virology; 2004 Jul; 324(2):483-92. PubMed ID: 15207633
[TBL] [Abstract][Full Text] [Related]
26. Correlation between Methylation of Human Papillomavirus-16 L1 Gene and Cervical Carcinoma in Uyghur Women.
Niyazi M; Sui S; Zhu K; Wang L; Jiao Z; Lu P
Gynecol Obstet Invest; 2017; 82(1):22-29. PubMed ID: 26954462
[TBL] [Abstract][Full Text] [Related]
27. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia.
Turan T; Kalantari M; Cuschieri K; Cubie HA; Skomedal H; Bernard HU
Virology; 2007 Apr; 361(1):185-93. PubMed ID: 17175003
[TBL] [Abstract][Full Text] [Related]
28. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression.
Badal V; Chuang LS; Tan EH; Badal S; Villa LL; Wheeler CM; Li BF; Bernard HU
J Virol; 2003 Jun; 77(11):6227-34. PubMed ID: 12743279
[TBL] [Abstract][Full Text] [Related]
29. Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes.
Galván SC; Martínez-Salazar M; Galván VM; Méndez R; Díaz-Contreras GT; Alvarado-Hermida M; Alcántara-Silva R; García-Carrancá A
BMC Genomics; 2011 Nov; 12():580. PubMed ID: 22118413
[TBL] [Abstract][Full Text] [Related]
30. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis.
Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Santos MA; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34206840
[TBL] [Abstract][Full Text] [Related]
31. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.
Kalantari M; Calleja-Macias IE; Tewari D; Hagmar B; Lie K; Barrera-Saldana HA; Wiley DJ; Bernard HU
J Virol; 2004 Dec; 78(23):12762-72. PubMed ID: 15542628
[TBL] [Abstract][Full Text] [Related]
32.
Franzen A; Vogt TJ; Müller T; Dietrich J; Schröck A; Golletz C; Brossart P; Bootz F; Landsberg J; Kristiansen G; Dietrich D
Oncotarget; 2018 Jan; 9(1):641-650. PubMed ID: 29416641
[TBL] [Abstract][Full Text] [Related]
33. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.
Cole L; Polfus L; Peters ES
PLoS One; 2012; 7(3):e32657. PubMed ID: 22448226
[TBL] [Abstract][Full Text] [Related]
34. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
Gheit T; Anantharaman D; Holzinger D; Alemany L; Tous S; Lucas E; Prabhu PR; Pawlita M; Ridder R; Rehm S; Bogers J; Maffini F; Chiocca S; Lloveras B; Kumar RV; Somanathan T; de Sanjosé S; Castellsagué X; Arbyn M; Brennan P; Sankaranarayanan R; Pillai MR; Gangane N; Tommasino M;
Int J Cancer; 2017 Jul; 141(1):143-151. PubMed ID: 28369859
[TBL] [Abstract][Full Text] [Related]
35. DNA Methylation at the Novel CpG Sites in the Promoter of MED15/PCQAP Gene as a Biomarker for Head and Neck Cancers.
Ovchinnikov DA; Wan Y; Coman WB; Pandit P; Cooper-White JJ; Herman JG; Punyadeera C
Biomark Insights; 2014; 9():53-60. PubMed ID: 25057238
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between TAP gene promoter methylation and cervical lesions with HPV infection in Uyghur women].
Aikuer G; Jiao Z; Wu XC; Ma JQ; Abudla A; Hasim A
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):438-42. PubMed ID: 22932452
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma.
Khanal S; Strickley JD; Ha T; Demehri S; Ghim SJ; Jenson AB; Redman RA; Joh JJ
Exp Mol Pathol; 2020 Dec; 117():104549. PubMed ID: 33007298
[TBL] [Abstract][Full Text] [Related]
38. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences.
de Villiers EM; Gunst K; Stein H; Scherübl H
Int J Cancer; 2004 Mar; 109(2):253-8. PubMed ID: 14750177
[TBL] [Abstract][Full Text] [Related]
39. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.
Citro S; Miccolo C; Medda A; Ghiani L; Tagliabue M; Ansarin M; Chiocca S
J Exp Clin Cancer Res; 2022 Feb; 41(1):59. PubMed ID: 35144669
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
